Unlike full regulatory approvals, EUAs are based on a risk-benefit analysis conducted during an emergency situation. Full approval requires extensive clinical data demonstrating safety and efficacy, whereas EUAs can be granted based on preliminary data when the potential benefits outweigh the risks. This allows for rapid deployment of interventions in response to urgent public health threats.